Before Jackson took office at ARPA-H, the agency’s chief data officer departed after disagreeing with the administration’s ...

Kiniksa (KNSA) shifts from survival to growth as Arcalyst nears blockbuster sales and pipeline KPL-387 readouts loom—get the ...

Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or ...

Scotland has approved its first CLDN18.2-targeted therapy for advanced gastric and GEJ cancer, expanding options for patients ...

As deaths rose and treatments failed, morale among healthcare workers was at an all-time low. During that time, Dr. David Thrasher received a call from an Eli Lilly executive announcing emergency use ...

Immunocore is expanding its ImmTAX platform into autoimmune disease, outlining plans at the 44th Annual JP Morgan Healthcare ...

The National Institute for Health and Care Excellence has approved a breakthrough combination treatment for lupus nephritis, offering new hope to nearly 12,000 people in England living with the ...

Cases of respiratory syncytial virus are increasing, but vaccines and antibody shots can keep young children out of the ...

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...

The results of the phase 3 MajesTEC-9 trial showcase teclistamab's efficacy for patients with relapsed/refractory multiple ...

Amid a surprisingly severe flu season and a Covid-19 resurgence, those highly contagious respiratory illnesses are drawing ...

Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...